Innovent to Present Multiple R&D Results of General Biomedicine Pipeline at the ADA's 85th Scientific Sessions
SAN FRANCISCO and SUZHOU, China, June 13, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
Ascletis Announces Poster Presentations on the Study Results of ASC30 and ASC47 at the 85th Scientific Sessions of American Diabetes Association (ADA)
HONG KONG, June 9, 2025 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that poster presentations on preliminary studies of its oral small molecule GLP-1 Receptor (GLP-1R) agonist ASC30 and adipose-targeted, muscle-preserving...
ADA and IPification Partner to Revolutionize Seamless Authentication for Digital Apps
SINGAPORE, Feb. 25, 2025 /PRNewswire/ -- ADA, a leader in data and AI-driven digital transformation and all-in-one authentication solutions, and IPification, a pioneer in seamless mobile authentication, have announced their strategic partnership to...
ADA Acquires Customore, Launching the Most Advanced Intelligent Commerce Solution for the CPG Industry
ADA strengthens its position as the leading Data and AI company and the largest integrated ecommerce player in the region with its industry-leading Intelligent Commerce solution that combines Customore's data accelerators and ADA's CoPilot for...
